Ignite Creation Date:
2024-05-06 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05036135
Status:
TERMINATED
Last Update Posted:
2024-06-21
First Post:
2021-08-16
Brief Title:
A Study of AV-101 Dry Powder Inhaled Imatinib in Patients With Pulmonary Arterial Hypertension PAH
Sponsor:
Aerovate Therapeutics
Organization:
Aerovate Therapeutics
Organization Data
Organization:
Aerovate Therapeutics
Class:
INDUSTRY
Study ID:
AV-101-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Aerovate Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None